ImmunoScape Partners with Singapore’s Experimental Drug Development Centre to Develop Novel T Cell Receptor-Based Therapeutics

SAN DIEGO & SINGAPORE–(BUSINESS WIRE)–The collaboration aims to produce off-the-shelf TCR-based bispecific molecules that could lead to more effective treatments for solid tumors.
Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks